MX9201183A - Quinazolinas, procedimiento para su obtencion y composicion farmaceutica que las contiene. - Google Patents

Quinazolinas, procedimiento para su obtencion y composicion farmaceutica que las contiene.

Info

Publication number
MX9201183A
MX9201183A MX9201183A MX9201183A MX9201183A MX 9201183 A MX9201183 A MX 9201183A MX 9201183 A MX9201183 A MX 9201183A MX 9201183 A MX9201183 A MX 9201183A MX 9201183 A MX9201183 A MX 9201183A
Authority
MX
Mexico
Prior art keywords
carbon atoms
alkyl
alkoxy
hydrogen
hydroxy
Prior art date
Application number
MX9201183A
Other languages
English (en)
Spanish (es)
Inventor
Graham Michael Fraser Bisset
Ann Lesley Jackman
Duncan Ian Jodrell
Original Assignee
British Tech Group
Ici Plc
Lc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by British Tech Group, Ici Plc, Lc filed Critical British Tech Group
Publication of MX9201183A publication Critical patent/MX9201183A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88—Oxygen atoms
    • C07D239/90—Oxygen atoms with acyclic radicals attached in position 2 or 3

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MX9201183A 1991-03-19 1992-03-18 Quinazolinas, procedimiento para su obtencion y composicion farmaceutica que las contiene. MX9201183A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919105771A GB9105771D0 (en) 1991-03-19 1991-03-19 Anti-cancer compounds

Publications (1)

Publication Number Publication Date
MX9201183A true MX9201183A (es) 1994-06-30

Family

ID=10691801

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9201183A MX9201183A (es) 1991-03-19 1992-03-18 Quinazolinas, procedimiento para su obtencion y composicion farmaceutica que las contiene.

Country Status (18)

Country Link
US (1) US5444061A (cg-RX-API-DMAC10.html)
EP (1) EP0509643A1 (cg-RX-API-DMAC10.html)
JP (1) JPH06505974A (cg-RX-API-DMAC10.html)
AU (1) AU655970B2 (cg-RX-API-DMAC10.html)
CA (1) CA2106583A1 (cg-RX-API-DMAC10.html)
CZ (1) CZ195393A3 (cg-RX-API-DMAC10.html)
FI (1) FI934106A7 (cg-RX-API-DMAC10.html)
GB (2) GB9105771D0 (cg-RX-API-DMAC10.html)
HU (1) HUT67177A (cg-RX-API-DMAC10.html)
IE (1) IE920853A1 (cg-RX-API-DMAC10.html)
IL (1) IL101281A0 (cg-RX-API-DMAC10.html)
MX (1) MX9201183A (cg-RX-API-DMAC10.html)
NO (1) NO933341L (cg-RX-API-DMAC10.html)
NZ (1) NZ242023A (cg-RX-API-DMAC10.html)
SK (1) SK100993A3 (cg-RX-API-DMAC10.html)
TW (1) TW203608B (cg-RX-API-DMAC10.html)
WO (1) WO1992016512A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA921985B (cg-RX-API-DMAC10.html)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9205907D0 (en) * 1992-03-18 1992-04-29 Cancer Res Inst Royal Anti-cancer compounds
GB9223352D0 (en) * 1992-11-06 1992-12-23 Ici Plc Tricyclic compounds
GB9408936D0 (en) * 1994-05-05 1994-06-22 Cancer Res Inst Anti-cancer compounds
MX9801716A (es) * 1995-08-30 1998-05-31 Searle & Co Derivados de meta-guanidina, urea, tiourea o acido aminobenzoico azaciclico, como antagonistas de integrina.
GB9904275D0 (en) 1999-02-24 1999-04-21 Cancer Res Campaign Tech Anti-cancer compounds
US7230000B1 (en) 1999-10-27 2007-06-12 Cytokinetics, Incorporated Methods and compositions utilizing quinazolinones
US7671200B2 (en) * 1999-10-27 2010-03-02 Cytokinetics, Inc. Quinazolinone KSP inhibitors
US6545004B1 (en) 1999-10-27 2003-04-08 Cytokinetics, Inc. Methods and compositions utilizing quinazolinones
US7009049B2 (en) * 2002-02-15 2006-03-07 Cytokinetics, Inc. Syntheses of quinazolinones
AU2003270015A1 (en) 2002-05-09 2003-12-02 Cytokinetics, Inc. Compounds, compositions, and methods
US7166595B2 (en) * 2002-05-09 2007-01-23 Cytokinetics, Inc. Compounds, methods and compositions
WO2003103575A2 (en) * 2002-05-23 2003-12-18 Cytokinetics, Inc. Compounds, compositions, and methods
CA2489367A1 (en) * 2002-06-14 2003-12-24 Cytokinetics, Inc. Compounds, compositions, and methods
US20030236430A1 (en) * 2002-06-21 2003-12-25 Allen David Robert Preparation of protected amino acids
WO2004009036A2 (en) 2002-07-23 2004-01-29 Cytokinetics, Inc. Compounds compositions and methods
EP1539180A4 (en) * 2002-08-21 2006-08-30 Cytokinetics Inc COMPOUNDS, COMPOSITIONS AND METHODS
WO2004034972A2 (en) 2002-09-30 2004-04-29 Cytokinetics, Inc. Compounds, compositions, and methods
JP2007510652A (ja) * 2003-11-03 2007-04-26 サイトキネティクス・インコーポレーテッド ピリミジン−4−オン化合物、組成物、および方法
WO2005046588A2 (en) * 2003-11-07 2005-05-26 Cytokinetics, Inc. Compounds, compositions, and methods
EP1692112A4 (en) * 2003-12-08 2008-09-24 Cytokinetics Inc COMPOUNDS, COMPOSITIONS, AND METHODS
TR201901010T4 (tr) 2007-04-11 2019-02-21 Merck & Cie 18F etiketli folatlar.
BR112017003745A2 (pt) 2014-08-29 2017-12-05 Tes Pharma S R L inibidores de semialdeído descarboxilase de ácido alfa-amino-beta-carboximucônico
EP3846793B1 (en) 2018-09-07 2024-01-24 PIC Therapeutics, Inc. Eif4e inhibitors and uses thereof
AR121506A1 (es) 2020-03-03 2022-06-08 Pic Therapeutics Inc Inhibidores del eif4e y sus usos
IL310924A (en) 2021-08-25 2024-04-01 Pic Therapeutics Inc Eif4e inhibitors and uses thereof
US12157732B2 (en) 2021-08-25 2024-12-03 PIC Therapeutics, Inc. eIF4E inhibitors and uses thereof

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0031237B1 (en) * 1979-12-19 1984-10-17 National Research Development Corporation Quinazoline derivatives, processes for their preparation, compositions containing them and their use as anti-cancer agents
GB8513754D0 (en) * 1985-05-31 1985-07-03 Jones T R Anti-cancer quinazoline derivatives
US4746659A (en) * 1985-12-30 1988-05-24 Sri International Diastereomers of 10-alkyl-10-deazaminopterins and process for preparing the same
US5187167A (en) * 1986-03-27 1993-02-16 Imperial Chemical Industries Plc Pharmaceutical compositions comprising quinazolin-4-one derivatives
GB8607683D0 (en) * 1986-03-27 1986-04-30 Ici Plc Anti-tumor agents
GB8625019D0 (en) * 1986-10-18 1986-11-19 Wellcome Found Compounds
GB8707053D0 (en) * 1987-03-25 1987-04-29 Ici Plc Anti-tumour agents
US4767761A (en) * 1987-11-04 1988-08-30 Dana-Farber Cancer Institute, Inc. Ornithine derivatives and their use as methotrexate-resistant cell inhibitors
GB8727737D0 (en) * 1987-11-26 1987-12-31 Ici Plc Antitumour agents
GB8809978D0 (en) * 1988-04-27 1988-06-02 Ici Plc Anti-tumour agents
US5252573A (en) * 1988-12-15 1993-10-12 Imperial Chemical Industries Plc Anti-tumor agents
GB8829296D0 (en) * 1988-12-15 1989-01-25 Ici Plc Anti-tumour compounds
US4996207A (en) * 1990-01-18 1991-02-26 Nair Madhavan G Three new non-polyglutamatable deazaaminopterins
DE69111891T2 (de) * 1990-05-17 1996-04-04 Smith & Nephew United Inc Elektrisch leitender und adstringierender Film sowie filmbildende Zusammensetzung zur Verwendung auf der Haut.
AU640016B2 (en) * 1990-05-30 1993-08-12 Imperial Chemical Industries Plc Hydroquinazoline derivatives

Also Published As

Publication number Publication date
HUT67177A (en) 1995-02-28
CA2106583A1 (en) 1992-09-20
ZA921985B (en) 1993-09-20
FI934106A7 (fi) 1993-11-18
JPH06505974A (ja) 1994-07-07
NO933341L (no) 1993-11-18
SK100993A3 (en) 1994-08-10
NZ242023A (en) 1993-12-23
TW203608B (cg-RX-API-DMAC10.html) 1993-04-11
GB2253849A (en) 1992-09-23
GB2253849B (en) 1995-01-18
IL101281A0 (en) 1992-11-15
FI934106A0 (fi) 1993-09-20
AU655970B2 (en) 1995-01-19
CZ195393A3 (en) 1994-07-13
WO1992016512A1 (en) 1992-10-01
GB9105771D0 (en) 1991-05-01
IE920853A1 (en) 1992-09-23
EP0509643A1 (en) 1992-10-21
AU1371692A (en) 1992-10-21
US5444061A (en) 1995-08-22
HU9302636D0 (en) 1993-12-28
GB9205906D0 (en) 1992-04-29
NO933341D0 (no) 1993-09-20

Similar Documents

Publication Publication Date Title
EA200000592A1 (ru) Азаполициклические соединения, конденсированные с арилом
RU2000127751A (ru) Противоопухолевое средство
ES2164663T3 (es) Derivados de paclitaxel unidos a polimeros.
ES2067456T3 (es) Nuevos derivados de aminoacidos, procedimientos para su preparacion y composicion farmaceutica que los comprende.
AR027464A1 (es) Oxamidas que son inhibidores de la inosina monofosfato deshidrogenasa (impdh)
ATE262329T1 (de) Formulierungen und verfahren zur verminderung der toxizität von anti-neoplastischen mitteln
KR890008113A (ko) 퀴녹살린 화합물 및 이의 제조방법 및 용도
CA2117543A1 (en) Dipeptidylquinazolones as anti-cancer agents
KR950703564A (ko) 뇌세포 보호제(Brain cell protective)
CY1112143T1 (el) Χρηση παραγωγων kykλοπenta[g]kinαζολινης για θεραπεια καρκινου
NO933341L (no) Fordindelser mot kreft
ATE338047T1 (de) Stickstoffbasierte camptothecin-derivate
NO800447L (no) Derivater av difenylhydantoin, farmasoeytiske preparater inneholdende slike preparater, samt fremgangsmaate til fremstilling av de aktive forbindelser
EA200200831A1 (ru) Фармацевтическая композиция, включающая пеметрексед вместе с монотиоглицерином, l-цистеином или тиогликолевой кислотой
EA199801028A1 (ru) Применение производных п-аминофенола для проготовления фармацевтических композиций, используемых при лечении нейродегенеративных заболеваний
CO5160242A1 (es) UTILIZACION DE DERIVADOS DE PIRIDAZINO [4,5-b] INDOL-1- ACETAMIDA, PARA LA PREPARACION DE MEDICAMENTOS DESTINADOS A LAS ENFERMEDADES DEL SISTEMA NERVIOSO CENTRAL
ES2090024T3 (es) Compuestos de cefemo y procedimientos para su preparacion.
MY118638A (en) 1,5-benzodiazepine derivatives
EA200000996A1 (ru) Конденсированные с арилом азаполициклические соединения
RU2009114731A (ru) Производное пиразолопиримидина
AR046874A1 (es) Nuevos metodos
BR0308071A (pt) Inibidores da protéina farnesil transferase como agentes antitumores
AR006991A1 (es) Analogo hidrosoluble de 20(s)- camptotecina, una composicion farmaceutica que los contiene, una medicina para el tratamiento del cancer, leucemia oestados relacionados con el hiv, el uso de dichos compuestos y un procedimiento para su preparacion
RU99115829A (ru) Новые аналоги камптотецина, их применение в качестве лекарственных средств и содержащие их фармацевтические композиции
MX9306529A (es) Derivados de pirazol condensado, metodo para fabricarlos y composicion farmaceutica que los contiene